Tag: Drugs Controller General of India
Regulatory Nod for Conducting Clinical Trials of Colchicine on COVID-19 Patients: CSIR
NEW DELHI:The Drugs Controller General of India (DCGI) has given approval to the CSIR and.
COVID-19: Zydus Cadila gets DGCI Nod for Phase 3 Clinical Trials with Biological Therapy
NEW DELHI:Drug firm Zydus Cadila on Friday said it has received the approval from the.
Nod to Serum Institute of India for Phase 2, 3 Human Clinical Trials of Oxford Vaccine Candidate
NEW DELHI: The Drugs Controller General of India (DCGI) has given nod to the Serum.